A Phase 1B Dose-escalation Study of TRC105 in Combination With Axitinib in Patients With Advanced Renal Cell Carcinoma

Sponsors and Collaborators
Tracon Pharmaceuticals Inc.

Contact
Bonne Adams
badams@traconpharma.com

Manoj Jivani
mjivani@traconpharma.com

ClinicalTrials.gov Identifier
NCT01806064